Joint

JYNT · NASDAQ

$7.19−$0.08 (−1.10%)TodayMarket closed ·
Prev close $7.27

About JYNT

The Joint Corp. engages in the revolutionizing access to chiropractic care by making quality healthcare affordable for patients seeking pain relief and ongoing wellness. The company is headquartered in Scottsdale, Arizona and currently employs 202 full-time employees. The company went IPO on 2014-11-11. The firm operates the Franchise Operations segment. The firm and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. The company offers a range of membership and wellness packages. The company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

Employees
202
Headquarters
Scottsdale, Arizona
Listed
Nov 11, 2014
Sector
Health Care
Industry
Health Care Providers & Services

JYNT key statistics

Market cap
101.69M
Price-earnings ratio
26.93
Dividend yield
—
Average volume
77.67K
Volume
40.13K
Open price
$7.27
High today
$7.40
Low today
$7.16
52 Week high
$10.67
52 Week low
$6.79

Joint (JYNT) at a glance

Joint (JYNT) last traded at $7.19, with a market cap of 101.69M and a price-to-earnings ratio of 26.93.

Today the stock has traded between $7.16 and $7.40. The current price is 0.5% above the day's low and 2.8% below its high.

Volume so far is 40.13K shares, below the average of 77.67K shares a day.

Over the past year Joint has ranged from $6.79 to $10.67, and now sits 10% of the way up that range.

Joint met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$0.01 per share against an estimate of $0.0476.

JYNT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 173.6% on average.

  1. Q3 FY24: reported -$0.21 per share against an estimate of $0.0082
  2. Q4 FY24: reported $0.06 per share against an estimate of $0.0102
  3. Q1 FY25: reported -$0.03 per share against an estimate of $0.00
  4. Q2 FY25: reported -$0.06 per share against an estimate of -$0.0179
  5. Q3 FY25: reported $0.02 per share against an estimate of $0.00
  6. Q4 FY25: reported $0.0675 per share against an estimate of $0.0408
  7. Q1 FY26: reported $0.08 per share against an estimate of $0.0332
  8. Q2 FY26: reported -$0.01 per share against an estimate of $0.0476

JYNT news

  • Press releasePRNewswire

    The Joint Chiropractic Expands Growth Opportunities Through Strategic Territory Reacquisition

  • Press releasePRNewswire

    The Joint Chiropractic Earns Entrepreneur Recognition as a Premier Multi-Unit Franchise Investment

  • Press releasePRNewswire

    The Joint Chiropractic Expands to 44th State with Opening of Rhode Island Clinic

  • Press releasePRNewswire

    The Joint Chiropractic® Names Michelle Reap as Director of Franchise Development

  • Press releasePRNewswire

    The Joint Chiropractic and Subaru of Utah Partner to Bring Chiropractic Care to over 275 Employees

  • Press releasePRNewswire

    Give Your Back a Break this Holiday with The Joint Chiropractic's "Back Friday Deals"

  • Earnings Scheduled For November 6, 2025

  • Press releasePRNewswire

    The Joint Chiropractic Continues Climb on the Franchise Times Top 400 List

Similar companies

Companies in the same industry as Joint

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.